≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Liver/bile ducts

Endpoint Browser

CD2_BENIGN_LIVE_BILE_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Liver/bile ducts based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 882 627 255
Unadjusted period prevalence (%) 0.18 0.21 0.11
Median age at first event (years) 53.11 49.51 61.98

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
765
Matched controls
7651
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.4
ICD-10 Finland
Benign neoplasm: Liver
4503599627370496.0
323.0
666
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
204.1
172.8
174
11
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
42.4
118.5
148
43
D13.5
ICD-10 Finland
Benign neoplasm: Extrahepatic bile ducts
+∞
90.4
85
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
34.7
76.7
100
33
130
Kela drug reimbursment
Malignant tumour
+∞
65.6
62
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
32.2
61.2
81
28
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.0
59.9
161
280
H02AB02
ATC
dexamethasone; systemic
21.0
41.6
62
32
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
13.5
37.5
66
53
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
35.5
355
1856
A04AA02
ATC
granisetron; systemic, transdermal
91.6
32.0
35
*
PJA12
NOMESCO Finland
Sentinel node biopsy
118.4
31.9
34
*
115
Kela drug reimbursment
Breast cancer
+∞
31.5
30
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
30.8
31.0
41
14
C61
ICD-10 Finland
Malignant neoplasm of prostate
314.1
30.0
30
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
28.3
27
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
27.8
263
1285
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.0
27.8
184
723
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
27.7
134
417
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
13.2
25.6
45
36
JN4BD
NOMESCO Finland
Extensive body CT
5.9
25.2
73
135
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
258.0
24.8
25
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.8
24.7
114
340
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
24.1
23
*
UJF32
NOMESCO Finland
Coloscopy
2.5
23.5
218
1037
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
23.3
148
561
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
23.0
22
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
20.9
20
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.6
19.9
34
26
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
75.5
19.8
22
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
205.0
19.6
20
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
18.8
18
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
18.8
18
*
K76.89
ICD-10 Finland
Other specified diseases of liver
71.7
18.8
21
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
102.6
18.6
20
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
194.5
18.6
19
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.0
18.1
45
68
L01BC06
ATC
capecitabine; oral
+∞
17.8
17
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
13.0
17.2
30
24
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.8
17.1
120
477
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
16.7
16
*
A02BC02
ATC
pantoprazole; systemic
1.9
16.6
489
3666
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
23.7
16.5
23
10
Z51.5
ICD-10 Finland
Palliative care
11.5
16.4
30
27
D18.0
ICD-10 Finland
Haemangioma, any site
6.7
15.9
40
62
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
15.7
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
15.6
203
1107
L03AA13
ATC
pegfilgrastim; parenteral
163.1
15.5
16
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
15.4
235
1368
XX3DW
NOMESCO Finland
Time consuming IT work
4.1
15.1
59
151
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
12.3
14.2
25
21
J01MA02
ATC
ciprofloxacin; systemic
1.9
14.0
290
1878
B01AB05
ATC
enoxaparin; parenteral
2.0
13.9
208
1191
A04AA01
ATC
ondansetron; systemic, rectal
5.4
13.7
41
80
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
13.6
13
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
13.6
13
*
HAC20
NOMESCO Finland
Total mastectomy
50.9
12.9
15
*
WX402
NOMESCO Finland
General anaesthesia
2.3
12.7
124
587
ZX120
NOMESCO Finland
Intravenous
3.2
12.7
67
221
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
12.5
12
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
12.5
12
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.4
12.5
18
9
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
12.3
195
1139
WF002
NOMESCO Finland
Radical radiotherapy
27.2
12.1
16
6
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.0
306
2093
UJK02
NOMESCO Finland
ERCP
7.7
12.0
27
36
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
47.4
11.9
14
*
JN4AD
NOMESCO Finland
Body CT examination
4.5
11.9
41
94
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
11.8
151
806
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
30.5
11.7
15
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
11.6
44
111
K76.80
ICD-10 Finland
Hepatic cyst
13.9
11.5
19
14
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
11.5
11
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.5
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.5
11
*
21150
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Hepatis
+∞
11.5
11
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.3
11.5
107
496
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
121.7
11.5
12
*
ZX080
NOMESCO Finland
Image guided radiotherapy
121.7
11.5
12
*
L02BA01
ATC
tamoxifen; oral
35.6
11.3
14
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
25.4
11.2
15
6
K83.1
ICD-10 Finland
Obstruction of bile duct
25.4
11.2
15
6
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
11.2
33
64
N02BE01
ATC
paracetamol; systemic, rectal
1.9
11.0
640
5562
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
11.0
151
831
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
44.0
10.9
13
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
10.9
41
103
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
10.9
45
123
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
111.5
10.4
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.4
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.3
275
1886
A02BC05
ATC
esomeprazole; systemic
1.7
10.2
299
2107
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
10.1
198
1233
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.2
10.1
52
170
R06.0
ICD-10 Finland
Dyspnoea
1.9
9.9
170
1010
HA1AA
NOMESCO Finland
X-ray mammography
4.1
9.7
37
94
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.5
105
526
X76
ICPC
Malignant neoplasm breast female
101.2
9.4
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
101.2
9.4
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
101.2
9.4
10
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
9.4
9
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.7
9.3
18
19
WZC30
NOMESCO Finland
Teaching
2.5
9.3
72
303
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
9.3
97
473
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.7
9.3
62
240
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
15.8
9.1
14
9
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
9.0
180
1120
UKC02
NOMESCO Finland
Cystoscopy
2.2
9.0
98
487
L02BG04
ATC
letrozole; oral
4.5
8.9
30
68
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
24.3
8.9
12
5
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
8.9
59
226
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.8
163
993
XKD00
NOMESCO Finland
Uroflowmetry
2.2
8.8
87
415
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
50.6
8.7
10
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
10.2
8.6
16
16
A02BC01
ATC
omeprazole; systemic
1.7
8.5
201
1318
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.7
8.4
35
97
ZX090
NOMESCO Finland
Other technic of radiotherapy
91.0
8.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
91.0
8.4
9
*
B01AB10
ATC
tinzaparin; parenteral
3.2
8.4
42
135
A02BC03
ATC
lansoprazole; oral
1.7
8.4
216
1451
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
8.3
8
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
8.3
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.3
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.3
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
8.3
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
8.1
126
720
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
8.1
113
618
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.1
267
1911
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
8.1
55
216
N02AA05
ATC
oxycodone; systemic
2.3
8.0
72
326
J01DB01
ATC
cefalexin; oral
1.7
7.9
600
5255
K83.0
ICD-10 Finland
Cholangitis
7.9
7.9
17
22
R4110
NOMESCO Finland
Physiotherapy
1.7
7.9
176
1130
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.3
7.8
27
64
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.8
301
2239
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
7.8
62
264
JJA20
NOMESCO Finland
Open biopsy of liver
45.4
7.7
9
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
25.3
7.6
10
*
K76.9
ICD-10 Finland
Liver disease, unspecified
5.8
7.6
20
35
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
10.2
7.6
14
14
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
80.8
7.4
8
*
JAH00
NOMESCO Finland
Laparotomy
4.4
7.4
25
58
R51.80
ICD-10 Finland
Headache
1.9
7.4
120
697
Z3231
NOMESCO Finland
Registered nurse
1.7
7.4
187
1243
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
7.3
7
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.0
7.2
27
69
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
7.2
91
480
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
4.5
7.2
24
55
NK6AN
NOMESCO Finland
Total body bone isotope imaging
20.2
7.1
10
5
J01MA12
ATC
levofloxacin; systemic
1.9
7.1
114
656
K30
ICD-10 Finland
Functional dyspepsia
2.0
7.1
86
446
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.2
6.8
24
58
S18
ICPC
Laceration/cut
1.5
6.8
256
1878
Z3226
NOMESCO Finland
Physiotherapist
1.8
6.8
130
797
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
40.4
6.8
8
*
L03AA02
ATC
filgrastim; parenteral
16.9
6.8
10
6
KCD02
NOMESCO Finland
Transurethral resection of bladder
16.9
6.8
10
6
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.0
6.7
38
132
WX110
NOMESCO Finland
Local anesthesy
1.5
6.7
493
4179
Y77
ICPC
Malignant neoplasm prostate
70.4
6.4
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
70.4
6.4
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
70.4
6.4
7
*
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
70.4
6.4
7
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
14.4
6.4
10
7
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
6.4
341
2694
R06AE07
ATC
cetirizine; oral
1.5
6.4
317
2465
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.9
6.3
36
126
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
6.3
76
394
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
6.3
6
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
3.2
6.3
31
101
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.1
6.2
14
20
JLC30
NOMESCO Finland
Pancreatoduodenectomy
26.9
6.2
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
6.2
56
257
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
7.8
6.1
13
17
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.6
6.1
164
1102
N03AX16
ATC
pregabalin; oral
1.6
6.1
157
1044
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
6.1
262
1970
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
12.6
6.1
10
8
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
8.7
6.1
12
14
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
6.1
64
315
JFB46
NOMESCO Finland
Resection of sigmoid colon
10.1
6.0
11
11
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
4.0
6.0
22
56
M03BX02
ATC
tizanidine; oral
1.5
6.0
454
3827
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
6.0
236
1738

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
281
272
14.69
268.71
2.5
1.5
ug/l
2.6
2.8
0.25
195
207
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
152
54
33.80
231.34
1.8
1.8
u/ml
3.5
78.7
0.49
152
49
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
168
107
19.16
201.26
2.1
1.9
u/ml
21.4
119.5
0.69
147
85
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
90
50
19.93
113.69
2.1
2.2
u/ml
134.5
87.6
0.15
83
45
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
650
3132
5.09
107.83
6.9
3.6
umol/l
10.5
10.8
0.35
625
2949
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
206
465
5.48
89.24
2.4
2.0
g/l
0.2
0.2
2.23
199
426
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
249
677
4.73
86.09
4.0
2.1
umol/l
5.2
5.8
0.61
221
574
(40768441) Liver Pathology biopsy report
66
34
20.90
85.87
1.3
1.2
—
—
—
0
0
(4035726)
114
185
6.93
68.90
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
514
2589
3.36
68.01
5.8
3.6
g/l
36.0
36.4
0.95
487
2408
(3032080) INR in Blood by Coagulation assay
465
2296
3.17
61.96
7.0
8.1
inr
1.1
1.2
1.03
99
688
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
766
5152
4.70
60.23
9.5
5.2
u/l
80.5
73.2
5.78
737
4781
(3033658) Prothrombin time (PT) actual/Normal
344
1537
3.03
52.85
5.9
3.1
%
96.6
93.3
1.51
336
1477
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
402
2088
2.70
44.79
3.2
2.2
u/l
57.3
56.3
0.16
371
1931
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
423
2294
2.62
42.61
4.2
2.6
u/l
31.3
29.2
0.98
408
2191
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
498
3004
2.51
38.90
4.0
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
296
1432
2.61
36.65
2.4
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
354
1882
2.47
35.66
2.6
1.9
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
80
180
4.79
33.59
1.3
1.1
titre
52.2
82.4
—
9
17
(3013826) Glucose [Moles/volume] in Serum or Plasma
569
3833
2.37
32.13
6.4
4.0
mmol/l
6.6
6.6
0.12
546
3510
(3013650) Neutrophils [#/volume] in Blood by Automated count
559
3779
2.31
30.68
8.7
6.6
e9/l
4.5
4.1
2.75
486
3306
(3034770) Mitochondria Ab [Titer] in Serum
78
189
4.43
29.83
1.3
1.2
—
881.4
—
0
7
(3002256) Pathology report gross observation
153
583
2.97
29.46
1.3
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
467
2983
2.20
28.77
8.9
5.3
mmol/l
1.2
1.2
0.05
417
2539
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
423
2643
2.15
27.04
8.3
4.9
mmol/l
1.2
1.2
0.01
391
2361
(40768804) Tissue Pathology biopsy report
401
2457
2.16
26.93
2.6
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
177
771
2.62
26.19
3.2
2.3
%
23.8
24.0
0.07
163
652
(3020779) Urea [Moles/volume] in Serum or Plasma
123
448
3.03
25.49
8.7
6.8
mmol/l
8.2
9.4
0.84
117
425
(3004789) Transferrin [Mass/volume] in Serum or Plasma
188
862
2.50
24.90
3.1
2.1
g/l
2.5
2.4
0.78
176
798
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
574
2.73
23.72
3.4
2.1
u/l
31.2
35.9
0.66
117
477
(3022948) Iron [Moles/volume] in Serum or Plasma
199
958
2.39
23.56
3.1
2.2
umol/l
13.9
14.0
0.06
189
877
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
650
4957
2.18
22.79
4.3
2.8
u/l
63.3
40.6
8.40
625
4677
(3019198) Lymphocytes [#/volume] in Blood
500
3528
1.96
20.91
6.1
5.5
e9/l
2.4
1.9
0.56
435
3145
(3001604) Monocytes [#/volume] in Blood
487
3421
1.95
20.47
6.1
5.4
e9/l
0.6
0.6
0.61
415
3003
(3006315) Basophils [#/volume] in Blood
488
3439
1.94
20.22
6.1
5.5
e9/l
0.0
0.0
0.34
417
3019
(3014576) Chloride [Moles/volume] in Serum or Plasma
147
658
2.48
20.21
11.1
6.5
mmol/l
105.2
104.4
1.59
147
643
(3013115) Eosinophils [#/volume] in Blood
501
3570
1.93
19.98
6.3
5.7
e9/l
0.2
0.2
0.63
430
3176
(3023368) Bacteria identified in Blood by Culture
250
1405
2.09
19.85
4.1
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
830
7223
3.53
19.28
17.0
10.5
mg/l
24.0
20.8
1.79
715
5495
(3013707) Erythrocyte sedimentation rate by Westergren method
669
5314
2.07
18.84
4.3
4.0
mm/h
11.8
10.7
1.20
628
4928
(3031040) Bacteria [#/volume] in Urine by Automated count
591
4532
1.92
17.97
5.0
4.0
e6/l
410.6
1971.7
—
7
62
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
119
509
2.55
17.92
4.0
3.2
u/l
224.4
235.1
0.57
113
481
(3003458) Phosphate [Moles/volume] in Serum or Plasma
153
735
2.31
17.83
6.8
4.7
mmol/l
1.0
1.0
0.32
140
668
(42870588) Differential panel, method unspecified - Blood
334
2143
1.90
17.76
6.3
5.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
459
3287
1.83
16.93
6.4
5.6
%
28.3
29.0
0.61
433
3067
(36304419) Bacteria [Presence] in Urine
270
1640
1.93
16.77
3.6
2.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
454
3259
1.81
16.44
6.3
5.4
%
58.1
56.7
1.91
429
3053
(3019069) Monocytes/100 leukocytes in Blood
446
3187
1.81
16.38
6.6
5.8
%
8.0
8.2
1.46
421
2984
(3006504) Eosinophils/100 leukocytes in Blood
444
3175
1.80
16.21
6.4
5.6
%
2.7
2.9
1.70
419
2954
(3018095) Leukocytes [#/volume] in Urine
340
2244
1.84
16.19
4.7
3.2
e6/l
39.8
102.8
1.99
231
1489
(3019550) Sodium [Moles/volume] in Serum or Plasma
829
7335
3.17
16.15
18.9
11.9
mmol/l
139.6
139.7
0.34
820
7121
(3030467) Casts [#/volume] in Urine by Automated count
269
1650
1.91
16.12
3.8
2.7
e6/l
0.3
0.4
0.30
186
1203
(3022096) Basophils/100 leukocytes in Blood
431
3065
1.79
15.94
6.4
5.6
%
0.6
0.7
0.77
405
2852
(3007164) IgA [Mass/volume] in Serum or Plasma
244
1455
1.94
15.89
1.5
1.3
g/l
2.1
2.3
1.53
168
917
(3002582) Erythrocytes [#/volume] in Urine
289
1822
1.87
15.86
4.1
2.8
e6/l
53.0
92.4
0.41
210
1368
(3023103) Potassium [Moles/volume] in Serum or Plasma
829
7358
3.11
15.60
18.9
12.0
mmol/l
3.9
4.0
1.47
819
7130
(3022145) Colonoscopy Study observation
140
693
2.21
15.04
1.4
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
106
466
2.45
14.98
4.1
3.6
ng/l
84.2
81.6
0.12
88
422
(3037467) Urinalysis macro (dipstick) panel - Urine
611
4871
1.83
14.86
4.7
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
164
872
2.08
14.65
4.0
2.5
mmol/l
0.8
0.8
0.48
149
801
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
170
921
2.05
14.42
3.5
2.6
e6/l
2.8
2.9
0.02
90
468
(40768797) Stomach Pathology biopsy report
175
968
2.01
13.98
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
19
8
24.23
13.82
1.3
2.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
306
2033
1.77
13.75
3.0
2.0
mmol/l
2.4
2.3
1.02
266
1738
(3017143) Hepatitis C virus Ab [Presence] in Serum
157
842
2.05
13.64
1.5
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
178
999
1.98
13.61
2.9
2.4
e6/l
1.4
1.0
0.31
95
543
(3036489) Thrombin time
65
234
2.92
13.61
2.8
1.9
s
23.2
20.9
0.58
57
203
(3003396) Base excess in Arterial blood by calculation
124
609
2.21
13.52
10.0
7.3
mmol/l
0.4
1.4
2.19
105
468
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
81
4.33
13.26
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
71
274
2.73
13.07
7.9
10.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
244
1539
1.81
12.94
7.3
4.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
167
934
1.97
12.85
1.9
1.7
%
1.4
1.4
0.20
151
836
(3048689) Calprotectin [Mass/mass] in Stool
167
934
1.97
12.85
2.1
2.4
ug/g
125.7
113.2
0.20
126
737
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
265
1730
1.76
12.43
1.3
1.3
u/ml
0.6
1.9
3.17
78
502
(3018418) pH of Serum or Plasma
264
1724
1.76
12.35
5.6
3.0
ph
7.4
7.4
0.75
36
285
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
248
1591
1.78
12.34
2.1
1.7
mg/l
1.0
1.0
0.15
195
1180
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
254
1681
1.72
11.15
2.5
2.1
mg/l
2.8
2.8
0.10
216
1428
(3037522) Nuclear Ab [Titer] in Serum
177
1055
1.85
11.11
1.5
1.3
titre
591.0
547.6
0.11
40
235
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
51
4.81
10.76
1.4
1.2
u/l
38.8
53.1
1.53
16
36
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
100
3.60
10.68
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
87
415
2.22
10.14
12.7
8.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
149
864
1.87
10.14
2.2
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
252
1703
1.67
10.08
2.9
2.2
umol/l
1325.8
5587.1
2.29
223
1476
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
81
379
2.25
9.89
1.5
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
100
511
2.08
9.78
3.0
2.0
ml/min/173m2
77.5
71.6
0.63
42
194
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
130
3.09
9.37
4.2
2.7
u/ml
0.3
0.4
1.16
17
68
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
6
21.96
9.37
5.8
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
175
2.78
9.29
1.5
1.4
ug/g
303.6
309.7
0.06
25
97
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
383
2912
1.56
9.21
2.9
2.3
nmol/l
72.7
76.7
2.25
348
2630
(3026782) Osmolality of Urine
183
1166
1.72
9.00
3.9
2.4
mosm/kgh2o
542.8
545.4
0.05
150
975
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
330
2449
1.56
8.72
3.3
3.2
ng/l
27.8
52.7
0.79
199
1477
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
187
1210
1.69
8.67
3.4
3.5
ng/l
1806.7
344.0
0.59
128
844
(3000850) Epithelial cells [#/volume] in Urine
192
1265
1.66
8.27
3.2
2.3
e6/l
5.3
7.9
1.41
160
1097
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
30
5.41
8.23
1.6
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
833
7749
2.35
8.13
13.7
8.2
u/l
29.3
25.3
6.80
816
7482
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
51
4.19
8.03
1.5
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
268
1934
1.55
7.86
2.7
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
168
1085
1.68
7.78
2.9
2.0
mmol/l
2.5
2.4
3.28
151
939
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
152
2.71
7.64
2.4
3.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
436
3507
1.48
7.52
4.1
3.2
estimate
0.0
0.0
0.00
61
625
(3021601) Nitrite [Presence] in Urine by Test strip
436
3510
1.48
7.47
5.6
4.5
estimate
0.0
0.0
0.50
65
625
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
36
131
2.82
7.46
2.5
1.3
mg/l
38.3
30.2
0.32
31
106
(3009261) Glucose [Presence] in Urine by Test strip
441
3562
1.48
7.41
4.0
3.3
estimate
0.0
0.0
0.80
62
609
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
748
6765
1.70
7.30
15.3
9.2
ml/min/173m2
86.3
84.6
1.28
633
5413
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
130
2.76
7.00
2.6
1.3
mg/l
45.0
40.0
0.24
30
106
(3003327) Ova and parasites identified in Stool by Light microscopy
53
242
2.27
6.89
1.7
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
224
1595
1.54
6.84
3.7
3.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
424
3435
1.45
6.80
3.9
2.7
ug/l
115.7
95.3
1.31
403
3219
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
61
297
2.13
6.79
1.9
2.2
u/l
42.2
39.8
0.45
56
270
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
349
2729
1.46
6.73
2.1
1.9
pmol/l
99.5
97.6
0.29
200
1419
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
36
4.51
6.73
4.6
1.1
u/ml
10.4
54.1
—
6
9
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
132
833
1.69
6.62
8.2
5.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
120
738
1.72
6.61
26.1
21.9
inr
1.3
1.3
0.03
12
106
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
214
1524
1.53
6.49
1.7
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
102
2.91
6.42
1.0
1.1
u/ml
5.6
6.2
0.06
13
39
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
28
97
2.95
6.36
1.0
1.0
u/ml
0.1
0.3
—
9
25
(3003888) Timothy IgE Ab [Units/volume] in Serum
35
137
2.62
6.35
1.0
1.1
u/ml
1.5
5.2
1.57
19
72
(3027945) Reticulocytes/100 erythrocytes in Blood
100
594
1.77
6.22
2.1
2.2
%
1.9
1.8
0.36
89
516
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
151
2.51
6.18
1.1
1.1
u/ml
0.7
2.2
0.79
13
59
(3007853) Bacteria identified in Skin by Aerobe culture
120
754
1.68
6.11
1.8
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
222
2.23
6.08
1.4
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
23
5.28
6.02
1.3
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
821
7711
1.94
5.94
16.2
10.1
—
—
—
0
0
(3044889) 12 lead EKG panel
562
4867
1.43
5.87
3.8
3.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
98
590
1.74
5.82
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
37
156
2.43
5.79
3.2
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
132
2.56
5.76
1.0
1.1
u/ml
0.3
0.9
1.74
12
58
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
626
1.71
5.66
1.7
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
372
3013
1.41
5.64
9.6
7.5
e9/l
0.0
0.0
0.72
293
2488
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
104
2.75
5.64
3.4
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
63
335
1.95
5.56
2.7
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
101
625
1.70
5.44
1.6
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
5
16.13
5.42
3.5
1.0
u/ml
21.0
16.0
—
8
5
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
213
2.17
5.41
1.9
1.9
g/l
1.5
1.4
0.19
38
184
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
34
4.17
5.37
2.1
1.5
u/l
4.4
9.7
—
9
17
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
58
3.33
5.33
1.2
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
58
3.33
5.33
1.3
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
13
30
4.38
5.31
2.2
2.1
nmol/l
2.2
9.8
—
8
19
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
56
291
1.99
5.28
1.6
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
73
415
1.83
5.26
1.1
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
126
2.51
5.25
1.0
1.0
u/ml
0.4
1.9
1.07
12
33
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
308
1.95
5.15
1.5
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
98
2.70
5.11
9.6
5.5
iu/ml
29837.2
212.2
—
5
13
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
221
1656
1.45
5.08
2.7
2.8
ng/l
1438.3
993.0
0.68
189
1386
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
652
5873
1.42
4.94
4.7
4.1
pmol/l
14.6
14.6
0.11
604
5426
(4010399)
85
516
1.72
4.92
1.6
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
84
509
1.72
4.89
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
134
913
1.55
4.89
1.7
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
63
351
1.86
4.85
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
173
1247
1.48
4.84
1.7
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
138
2.37
4.80
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
73
428
1.77
4.77
2.4
2.3
e9/l
67.0
71.1
0.64
57
322
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
114
2.50
4.75
1.0
1.0
u/ml
1.4
2.9
0.80
14
41
(3003694) ABO and Rh group [Type] in Blood
247
1909
1.41
4.75
1.4
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
38
179
2.17
4.66
2.2
1.8
ug/l
4.6
1.3
0.44
31
160
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
28
117
2.44
4.51
1.5
1.2
u/ml
1.9
8.4
1.34
13
44
(3005322) IgE [Units/volume] in Serum or Plasma
84
521
1.68
4.50
1.2
1.2
u/ml
115.5
237.6
1.61
77
481
(3019060) Gas panel - Arterial blood
62
354
1.81
4.44
7.5
4.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
77
470
1.70
4.38
3.2
3.2
pmol/l
4.5
4.6
0.31
69
410
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
13
35
3.75
4.37
2.7
3.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
95
2.57
4.33
2.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
72
2.82
4.31
1.4
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
253
1992
1.38
4.30
2.1
2.1
u/l
152.8
195.1
0.48
239
1880
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
742
6901
1.47
4.26
5.7
4.8
mu/l
1.7
2.0
1.06
697
6405
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
51
3.18
4.22
1.4
1.5
—
—
—
0
0
(4268621)
21
79
2.70
4.18
2.8
2.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
26
109
2.43
4.18
1.5
1.2
u/ml
1.3
3.8
—
9
34
(3002385) Erythrocyte distribution width [Ratio]
671
6141
1.39
4.12
21.4
12.6
%
13.7
13.6
1.17
665
5998
(4306422)
26
110
2.41
4.10
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
43
224
1.97
4.08
10.3
4.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
36
177
2.08
4.00
10.9
3.9
mmol/l
3.8
3.8
0.25
36
167
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
99
2.46
4.00
1.2
1.0
—
—
—
0
0
(3012544) pH of Venous blood
82
522
1.63
3.99
4.9
3.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
28
3.97
3.98
1.1
1.3
ug/l
16.1
15.7
0.05
11
28
(3020961) Endomysium IgA Ab [Titer] in Serum
64
382
1.73
3.96
1.1
1.1
—
186.6
—
0
10
(3011412) CD3 cells [#/volume] in Blood
13
38
3.46
3.91
2.6
2.2
e9/l
1.5
1.2
—
6
20
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
113
2.34
3.88
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
93
616
1.57
3.85
4.0
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
67
409
1.69
3.84
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
15
6.05
3.82
3.4
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
81
521
1.61
3.79
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
39
3.37
3.77
1.2
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
55
2.94
3.75
2.4
2.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
99
670
1.54
3.73
2.0
1.8
nmol/l
397.5
368.8
0.60
84
616
(3020630) Protein [Mass/volume] in Serum or Plasma
71
444
1.65
3.72
2.1
1.5
g/l
66.7
67.9
0.70
64
400
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
142
2.15
3.68
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
77
494
1.61
3.65
2.1
2.5
e9/l
4.4
4.1
0.49
53
390
(4281824)
13
40
3.28
3.63
1.4
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
81
527
1.59
3.63
2.0
2.3
ug/l
7.2
6.8
0.06
72
463
(3018405) Lactate [Moles/volume] in Arterial blood
40
213
1.92
3.59
10.0
3.6
mmol/l
1.1
1.4
1.43
40
207
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
105
2.32
3.55
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
200
1559
1.37
3.55
1.6
1.5
nmol/l
18.8
21.4
1.99
172
1352
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
229
1.88
3.52
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
365
1.69
3.50
2.0
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
78
508
1.59
3.48
5.1
3.2
mmol/l
2.0
2.2
0.24
65
399
(3013512) EKG study
227
1823
1.33
3.29
4.1
3.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
163
2.00
3.28
3.1
3.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
154
1165
1.39
3.27
1.7
1.7
nmol/l
1079.6
1203.5
1.02
121
880
(40761535) Cells panel - Urine sediment
79
525
1.55
3.25
3.6
3.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
19
4.77
3.24
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
38
3.19
3.22
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
38
3.19
3.22
1.2
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
48
282
1.74
3.19
1.3
1.7
—
9.1
—
0
7
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
16
5.04
3.05
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
16
5.04
3.05
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
16
5.04
3.05
1.0
1.1
%
88.1
103.9
—
8
16
(3007461) Platelets [#/volume] in Blood
847
8208
1.80
3.02
26.5
15.7
e9/l
266.3
257.7
2.80
829
8006
(3028433) Virus identified in Specimen by Culture
9
21
4.32
3.00
1.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
5
10.05
2.98
8.4
5.0
mmol/l
5.8
7.6
—
5
5
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
323
2750
1.28
2.98
4.4
3.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
847
8212
1.79
2.95
26.5
15.7
fl
90.3
90.6
1.37
839
8091
(3035941) MCH [Entitic mass]
847
8214
1.79
2.92
26.5
15.7
pg
30.0
30.2
3.38
839
8092
(3026361) Erythrocytes [#/volume] in Blood
847
8215
1.78
2.90
26.6
15.7
e12/l
4.5
4.5
0.55
831
7992
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
43
252
1.74
2.90
1.7
1.5
g/l
1.3
1.2
0.65
43
238
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
22
4.12
2.88
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
58
2.61
2.88
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
178
1405
1.33
2.88
1.3
1.3
iu/ml
26.9
34.3
0.38
48
441
(3010813) Leukocytes [#/volume] in Blood
847
8217
1.78
2.87
26.6
15.8
e9/l
7.1
6.6
7.86
831
7989
(3042733) HLA Ab [Presence] in Serum
7
13
5.42
2.87
2.9
4.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
847
8220
1.77
2.82
26.7
15.8
g/l
134.2
135.8
3.02
840
8098
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
118
876
1.40
2.80
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
92
653
1.46
2.79
1.7
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
196
1.82
2.75
2.5
1.3
g/l
2.8
3.0
0.85
27
154
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
6
8.37
2.75
1.2
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
190
1524
1.31
2.74
1.6
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
359
1.60
2.72
3.4
2.1
nmol/l
12.5
13.2
0.25
46
317
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
119
2.05
2.68
1.7
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
251
2098
1.27
2.64
3.7
3.0
mmol/l
7.9
7.7
0.42
223
1788
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
170
1350
1.32
2.63
1.3
1.3
u/ml
16.7
12.5
0.24
77
527
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
134
1.97
2.62
1.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
207
1.77
2.61
2.5
1.3
g/l
3.9
3.9
0.05
27
151
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
207
1.77
2.61
2.5
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
207
1.77
2.61
2.5
1.3
g/l
6.9
7.4
1.27
27
159
(3023323) Follitropin [Units/volume] in Serum or Plasma
70
478
1.50
2.58
1.4
1.3
iu/l
25.5
27.8
0.25
59
415
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
20
4.03
2.57
1.5
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
94
2.15
2.56
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
81
2.25
2.55
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
82
2.22
2.48
1.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
82
2.22
2.48
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
35
203
1.75
2.48
3.8
2.5
g/l
0.2
0.3
0.54
19
68
(3043410) Blood group antigens tested for on Red Blood Cells
8
21
3.83
2.46
1.3
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
173
0.34
2.43
1.7
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
43
266
1.65
2.43
2.7
3.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
39
235
1.69
2.42
2.6
4.3
%
1.7
1.6
0.13
39
223
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
58
2.44
2.38
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
52
2.52
2.36
1.5
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
46
2.63
2.36
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
113
859
1.36
2.34
3.0
2.5
ug/l
0.8
0.7
0.62
80
556
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
59
2.40
2.30
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
85
2.14
2.30
1.3
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
85
2.14
2.30
1.3
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
85
2.14
2.30
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
13
4.64
2.27
1.8
2.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
256
1.63
2.25
2.0
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
240
2030
1.25
2.24
4.6
3.9
mg/mmol
15.1
8.2
0.75
171
1269
(40768806) Pleura Pathology biopsy report
9
29
3.12
2.23
2.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
29
3.12
2.23
1.2
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
40
249
1.64
2.22
7.2
3.2
mmol/l
24.4
24.5
0.07
35
219
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
9
5.58
2.21
1.6
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
24
3.35
2.18
3.5
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
228
1925
1.25
2.16
3.8
3.2
mg/l
811.7
264.4
0.67
159
1204
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
703
6665
1.27
2.16
6.5
5.3
mmol/mol
39.8
39.2
1.05
665
6243
(3009542) Hematocrit [Volume Fraction] of Blood
723
6879
1.28
2.15
20.2
11.6
%
39.7
40.0
0.40
555
5187
(3000494) Fungus identified in Specimen by Culture
104
792
1.35
2.14
1.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
72
515
1.43
2.14
1.7
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
190
1.71
2.12
2.7
1.3
g/l
10.0
10.6
0.48
27
164
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
109
1.95
2.12
1.6
1.3
u/ml
91.3
118.6
—
6
23
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
366
1.51
2.10
1.7
2.1
u/l
5040.2
3408.8
0.20
17
155
(3034426) Prothrombin time (PT)
8
25
3.22
2.10
1.8
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
25
3.22
2.10
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
199
1660
1.26
2.09
3.3
4.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
15
4.02
2.04
1.2
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
190
1583
1.26
2.02
4.8
3.5
kg/l
1.0
1.0
0.46
24
231
(3020874) Milk IgE Ab [Units/volume] in Serum
11
44
2.52
2.01
1.1
1.0
u/ml
1.6
0.3
—
5
15
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
57
2.30
1.98
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
105
1.93
1.97
2.2
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
736
7040
1.27
1.94
4.3
3.7
mmol/l
1.4
1.3
5.48
687
6535
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
120
1.85
1.94
1.3
1.2
u/ml
180.5
237.5
0.94
11
74
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
16
3.77
1.93
1.2
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
16
3.77
1.93
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
92
1.98
1.91
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
114
1.86
1.88
1.5
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
40
261
1.56
1.87
2.9
3.4
%
40.5
48.2
1.30
40
256
(40761536) Microorganisms panel - Urine sediment
38
572
0.65
1.87
5.4
3.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
79
2.04
1.86
1.4
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
46
2.41
1.85
1.3
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
181
1515
1.24
1.84
5.2
3.8
ug/l
2.7
1.9
1.74
170
1351
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
40
2.52
1.84
2.9
4.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
17
3.55
1.84
1.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
223
1.59
1.81
1.5
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
239
1.57
1.81
1.5
1.6
iu/ml
0.1
0.1
—
10
42
(3018572) Chloride [Moles/volume] in Blood
22
123
1.81
1.81
3.0
6.1
mmol/l
103.1
104.9
0.81
22
113
(3039000) Anion gap in Blood
22
123
1.81
1.81
3.0
6.1
mmol/l
11.5
11.1
0.19
22
113
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
149
1223
1.26
1.80
4.1
3.6
%
21.5
23.8
1.34
85
553
(3029937) Albumin [Presence] in Urine by Test strip
215
1838
1.22
1.80
4.8
3.5
estimate
0.0
0.0
0.88
63
620
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
762
7337
1.28
1.78
4.9
4.2
mmol/l
4.7
4.7
0.73
723
6887
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
60
2.18
1.78
1.6
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
95
1.91
1.76
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
6
18
3.35
1.75
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
36
2.52
1.74
1.4
2.3
u/ml
4305.0
647.9
—
9
36
(3026692) Albumin [Mass/volume] in Peritoneal fluid
5
13
3.86
1.71
1.0
1.8
g/l
10.4
11.5
—
5
8
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
118
1.80
1.71
1.4
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
134
1.74
1.67
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
52
369
1.43
1.66
3.0
3.1
kpa
5.1
5.2
0.06
44
345
(4062490)
15
77
1.96
1.60
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
106
1.81
1.59
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
106
1.81
1.59
1.2
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
20
3.01
1.58
3.0
1.8
ug/l
59.2
55.9
—
6
20
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
757
7306
1.25
1.57
4.8
4.2
mmol/l
1.5
1.5
2.15
711
6829
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
71
1.99
1.54
1.4
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.53
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
350
1.42
1.53
3.1
3.0
mmol/l
1.4
1.8
0.37
39
262
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
61
454
1.37
1.51
5.0
2.1
mmol/l
1.2
1.2
0.45
55
376
(40768446) Kidney Pathology biopsy report
6
21
2.87
1.50
1.8
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
40
276
1.47
1.49
2.8
3.0
mmol/l
25.3
25.4
0.06
40
267
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
104
837
1.27
1.49
4.5
4.4
%
31.2
32.1
0.34
69
578
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
72
1.96
1.49
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
551
5184
1.17
1.44
3.7
3.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
22
2.74
1.43
2.7
2.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
18
103
1.76
1.41
1.1
1.2
nmol/l
0.5
0.6
0.69
18
97
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
736
7101
1.22
1.41
4.8
4.2
mmol/l
5.9
5.8
1.25
691
6556
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
64
486
1.34
1.41
1.3
1.3
—
43.6
—
0
24
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
81
1.87
1.40
2.7
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
220
1929
1.19
1.40
1.7
1.7
mmol/l
1.6
1.4
2.35
199
1656
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
67
1.95
1.38
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
60
2.01
1.38
2.8
4.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
18
104
1.75
1.37
1.1
1.2
nmol/l
—
0.7
—
0
8
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
41
2.21
1.37
1.1
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
23
2.62
1.37
1.2
2.0
e9/l
0.2
0.1
—
6
23
(3037756) Immunofixation for Serum or Plasma
14
75
1.88
1.35
1.8
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
98
1.75
1.31
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
36
251
1.45
1.30
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
145
1.60
1.30
1.4
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
55
2.01
1.27
1.5
1.5
—
—
—
0
0
(3000492) Spirometry study
88
710
1.27
1.26
1.5
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
25
2.41
1.24
1.7
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
25
2.41
1.24
1.7
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
45
2.01
1.23
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
63
1.92
1.23
1.1
1.1
—
—
—
0
0
(44790047)
12
63
1.92
1.23
1.6
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
63
1.92
1.23
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
63
1.92
1.23
1.1
1.1
—
—
—
0
0
(44806118)
12
63
1.92
1.23
1.6
1.5
—
—
—
0
0
(44790048)
12
63
1.92
1.23
1.6
1.5
—
—
—
0
0
(44790049)
12
63
1.92
1.23
1.6
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
26
2.32
1.19
1.7
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
64
1.89
1.18
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
64
1.89
1.18
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
64
1.89
1.18
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
215
1.46
1.17
1.3
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
20
2.51
1.15
1.6
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
765
7442
1.21
1.14
5.4
4.6
mmol/l
2.7
2.8
1.88
721
6954
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
47
353
1.35
1.14
1.5
1.5
—
—
—
0
0
(4133840)
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
21
2.39
1.09
1.6
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
41
1.96
1.09
1.9
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
221
1981
1.15
1.06
3.9
2.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
52
1.93
1.06
1.4
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
60
474
1.29
1.05
3.9
4.3
%
0.1
0.0
0.18
12
88
(42529406) Shigella sp [Presence] in Stool by Culture
31
221
1.42
1.04
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
221
1.42
1.04
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
46
1.97
1.03
2.3
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
22
2.28
1.03
1.2
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
34
2.07
1.03
2.1
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
213
1.42
1.03
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
494
0.74
1.03
1.4
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
9
47
1.92
1.02
2.3
2.2
ml
621.4
575.9
—
9
28
(3000093) Morphology [Interpretation] in Blood Narrative
9
47
1.92
1.02
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
68
1.78
1.01
1.6
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
214
1.42
1.01
1.3
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
7
35
2.01
1.00
2.1
2.1
min
498.6
493.2
—
7
23
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
319
1.33
0.98
1.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
48
372
1.31
0.98
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
243
1.37
0.94
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
269
1.35
0.94
1.4
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
30
218
1.39
0.92
1.4
1.2
u/ml
1.6
2.6
—
5
27
(3011288) Drugs identified in Urine by Screen method
28
201
1.41
0.92
1.9
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
134
1.50
0.92
1.0
1.0
u/ml
1.3
2.4
—
9
65
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
152
1.46
0.88
1.5
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
8
42
1.91
0.88
1.5
1.6
—
1.4
—
0
7
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
124
1080
1.17
0.88
2.2
2.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
56
1.79
0.88
1.1
1.6
nmol/l
1.8
1.5
—
10
49
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
204
1.38
0.86
1.2
1.3
u/l
11.6
10.4
0.15
18
167
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
104
1.55
0.85
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
20
137
1.47
0.84
1.4
1.3
u/l
23.9
25.8
0.09
15
107
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
121
1.50
0.83
1.1
1.4
nmol/l
0.3
0.4
0.78
13
104
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
146
1.45
0.83
1.4
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
223
1.36
0.82
1.4
1.2
u/ml
5.1
9.5
—
8
42
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
163
1.42
0.82
2.6
2.3
ug/min
68.0
126.9
0.56
15
106
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
113
1.51
0.82
1.6
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
60
491
1.24
0.82
3.9
4.2
%
1.1
0.7
0.15
12
97
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
201
0.64
0.82
2.2
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
81
1.61
0.81
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
262
2831
0.89
0.80
2.6
2.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.2
g/l
0.3
0.3
—
6
27
(3014051) Protein [Presence] in Urine by Test strip
9
151
0.59
0.79
1.2
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
48
1.67
0.79
1.1
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
160
1434
1.14
0.78
1.6
1.7
pmol/l
418.7
36132112.0
2.02
136
1215
(3045788) Cell count panel - Pleural fluid
6
34
1.77
0.76
2.5
1.3
—
—
—
0
0
(44813793)
10
59
1.70
0.76
1.1
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
99
1.52
0.76
2.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
170
1536
1.13
0.74
1.9
1.8
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
55
1.64
0.73
3.3
1.7
nmol/l
15.1
20.8
—
9
50
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
25
2.01
0.72
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
60
1.67
0.72
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
68
1.63
0.72
1.4
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
40
1.76
0.71
1.1
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
40
1.76
0.71
1.9
1.4
—
322.0
—
0
5
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
968
1.16
0.71
2.0
2.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
26
1.93
0.70
1.6
2.8
%
182.1
110.5
—
5
26
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
41
1.71
0.70
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
307
0.74
0.69
1.5
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
27
1.86
0.68
1.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
38
303
1.27
0.67
1.4
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
43
1.63
0.67
3.4
2.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
38
304
1.26
0.66
1.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
55
459
1.21
0.66
3.6
4.1
%
0.0
0.3
—
9
74
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.6
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
242
1.29
0.65
1.7
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
38
306
1.25
0.63
1.4
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
71
1.56
0.62
4.7
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.3
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
49
1.64
0.62
1.1
1.1
—
16.3
—
0
8
(3036670) Protein [Mass/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.2
—
37.8
—
0
12
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
201
1.30
0.59
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
274
0.76
0.56
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
274
0.76
0.56
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
37
302
1.24
0.56
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
221
1.28
0.56
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
54
459
1.19
0.55
3.8
4.3
%
0.0
1.2
—
10
78
(21494755) Public health laboratory ask at order entry panel
78
886
0.87
0.55
1.4
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
273
0.76
0.55
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
273
0.76
0.55
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
18
133
1.36
0.55
1.3
1.1
—
14.7
—
0
11
(3042631) Mycobacterium sp identified in Specimen
9
60
1.51
0.54
2.7
2.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
38
1.58
0.54
2.5
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
125
1.37
0.54
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
74
1.49
0.53
1.0
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
108
1.40
0.53
1.7
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
91
1.43
0.53
1.8
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
63
1.43
0.52
1.0
1.0
mg/l
180.2
220.1
—
9
52
(3016879) Cocaine [Presence] in Urine
35
287
1.23
0.52
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
100
1.41
0.52
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
110
1.37
0.49
1.5
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
67
589
1.15
0.48
1.2
1.2
iu/ml
148.2
146.3
0.01
24
242
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
231
0.77
0.45
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
458
0.84
0.44
2.2
2.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
127
0.71
0.43
1.8
4.1
%
60.1
57.3
—
9
127
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
31
1.62
0.43
1.0
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.42
1.1
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
33
1.52
0.41
1.0
1.2
%
100.8
113.2
—
5
26
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
33
1.52
0.41
1.0
1.4
u/l
183.8
190.8
—
5
33
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
16
0.00
0.41
0.0
1.4
—
2.2
—
0
16
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
38
326
1.17
0.38
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
66
1.37
0.38
1.2
1.1
mg/l
33.4
32.3
—
9
51
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
225
0.80
0.38
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
113
0.71
0.37
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
224
0.80
0.37
1.3
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
37
1.35
0.37
2.0
1.5
nmol/l
140.6
144.5
—
5
37
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
17
134
1.27
0.37
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
51
575
0.88
0.36
3.2
2.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
78
0.64
0.35
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
2.7
1.2
—
—
—
0
0
(4034850)
21
255
0.82
0.35
4.7
8.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
298
0.83
0.35
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
125
0.72
0.35
1.8
3.8
e9/l
4.9
4.3
—
9
125
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
233
0.81
0.35
1.4
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
43
1.40
0.35
1.7
1.0
—
1.1
—
0
16
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
338
0.85
0.32
1.6
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
83
1.33
0.32
1.1
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
92
1.31
0.32
1.6
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.6
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
75
1.34
0.30
1.2
1.1
—
—
—
0
0
(4027681)
7
56
1.25
0.29
1.0
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.3
1.4
—
63.6
—
0
7
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
57
1.23
0.29
1.4
1.1
—
2.2
—
0
5
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
39
347
1.13
0.27
1.4
1.7
mg/l
3.9
3.2
0.20
29
235
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
539
0.90
0.25
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
73
1.24
0.25
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
14
114
1.23
0.25
1.1
1.1
—
71.4
—
0
24
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
25
217
1.16
0.24
1.5
1.9
iu/l
1.8
5.2
—
6
89
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
97
1.24
0.23
1.2
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
5
39
1.28
0.23
1.2
2.1
mmol/l
7.4
9.6
—
5
32
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
40
1.25
0.22
1.8
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
116
1.21
0.22
1.1
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.1
—
0.6
—
0
11
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
6.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
126
1.19
0.21
1.2
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
5.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
6.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
37
336
1.11
0.20
1.3
1.5
mu/l
275.7
321.6
0.56
32
304
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
144
0.83
0.20
1.8
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
60
1.17
0.18
1.9
2.0
pg
32.4
32.5
—
7
60
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
176
1.14
0.17
1.2
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
63
1.11
0.17
1.4
1.1
—
94.4
—
0
5
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
72
759
0.94
0.15
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
293
1.10
0.15
1.8
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
121
1.16
0.15
4.0
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
18
160
1.13
0.14
5.5
4.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
84
1.19
0.14
1.1
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
87
905
0.96
0.12
1.6
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
32
297
1.08
0.12
1.1
1.3
miu/ml
221.1
243.5
0.19
16
151
(3000475) Leukocytes [#/volume] in Synovial fluid
18
162
1.11
0.12
1.6
1.6
e6/l
6111.9
12724.8
—
10
118
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
124
1.13
0.11
2.5
2.0
g/l
129.9
131.4
—
7
90
(4094501)
17
187
0.91
0.10
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
154
1.11
0.10
1.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
44
1.14
0.10
1.4
1.4
mmol/l
5.1
6.2
—
5
44
(3044941) Cell count panel - Synovial fluid
12
106
1.13
0.10
1.3
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
45
1.11
0.10
1.4
1.9
%
11.0
10.3
—
5
45
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.3
promille
1.2
1.4
—
6
43
(4146454)
7
68
1.03
0.08
4.3
2.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
68
1.03
0.08
1.0
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
90
0.89
0.06
3.8
2.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
443
1.04
0.06
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
162
0.92
0.06
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
109
0.92
0.04
4.0
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
131
1.07
0.03
1.5
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
96
951
1.01
0.01
1.9
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
134
1.05
0.00
1.6
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
141
0.99
0.00
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
141
0.99
0.00
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
327
1.01
0.00
4.2
3.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
53
533
0.99
0.00
1.8
1.7
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
73
0.96
0.00
3.1
2.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
66
0.91
0.00
1.2
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
43.7
—
0
6
(3023419) Bacteria identified in Sputum by Culture
8
81
0.99
0.00
2.0
2.8
—
—
—
0
0
(4024509)
5
51
0.98
0.00
2.0
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
75
0.93
0.00
3.1
2.4
mmol/l
4.5
4.1
—
7
75
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
53
0.94
0.00
1.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
75
0.93
0.00
3.1
2.4
mmol/l
107.9
105.9
—
7
75
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
7.2
—
0
7
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIVE_BILE_EXALLC – Benign neoplasm: Liver/bile ducts

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).